Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

Published

Journal Article

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.

Full Text

Duke Authors

Cited Authors

  • Carroll, PR; Parsons, JK; Andriole, G; Bahnson, RR; Barocas, DA; Catalona, WJ; Dahl, DM; Davis, JW; Epstein, JI; Etzioni, RB; Giri, VN; Hemstreet, GP; Kawachi, MH; Lange, PH; Loughlin, KR; Lowrance, W; Maroni, P; Mohler, J; Morgan, TM; Nadler, RB; Poch, M; Scales, C; Shanefelt, TM; Vickers, AJ; Wake, R; Shead, DA; Ho, M; National comprehensive cancer network,

Published Date

  • September 2014

Published In

Volume / Issue

  • 12 / 9

Start / End Page

  • 1211 - 1219

PubMed ID

  • 25190691

Pubmed Central ID

  • 25190691

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2014.0120

Language

  • eng

Conference Location

  • United States